HedgeChatter

  • Home /
  • Tag Archives

POZN

POZEN’s (PZN) CEO John Plachetka on Q1 2014 Results – Earnings Call Transcript

[at Seeking Alpha] – John Plachetka Thank you, Stephanie. Good morning to everybody and thanks for joining us today. Let me start by commenting on the first quarter results for VIMOVO. What a great change for this product … moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring […]

May 8, 2014 Bystocknews , Comments Off on POZEN’s (PZN) CEO John Plachetka on Q1 2014 Results – Earnings Call Transcript read more

POZEN Reports First Quarter 2014 Results

[Business Wire] – POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the first quarter ended March 31, 2014. moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring next, click here to view […]

May 8, 2014 Bystocknews , Comments Off on POZEN Reports First Quarter 2014 Results read more

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. – POZN

[PR Newswire] – NEW YORK, April 28, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Pozen, Inc. (Pozen or the Company) (POZN) (CUSIP:73941U102). Investors are advised to contact Robert S. Willoughby at rswilloughby@po moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring next, […]

April 28, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. – POZN read more

POZEN’S PA8140/PA32540 Receives a Complete Response Letter From FDA Citing Issues at a Facility of a Third Party Supplier of an Active Ingredient

[Business Wire] – POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, announced today that their drug candidates PA8140/PA32540 delayed release tablets have received a complete response letter from the U.S. moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring next, click here to […]

April 26, 2014 Bystocknews , Comments Off on POZEN’S PA8140/PA32540 Receives a Complete Response Letter From FDA Citing Issues at a Facility of a Third Party Supplier of an Active Ingredient read more

7:32 am POZEN misses by $0.02, beats on revs

moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring next, click here to view […]

March 6, 2014 Bystocknews , Comments Off on 7:32 am POZEN misses by $0.02, beats on revs read more

POZEN Announces March 5th Webcast of Fourth Quarter and Year End 2013 Results

[Business Wire] – POZEN Inc. , a pharmaceutical company committed to transforming medicine that transforms lives, announced today that it plans to release fourth quarter and year end 2 moreView todays social media effects on POZNView the latest stocks trending across Twitter. Click to view dashboardSee who Pozen is hiring next, click here to view […]

February 26, 2014 Bystocknews , Comments Off on POZEN Announces March 5th Webcast of Fourth Quarter and Year End 2013 Results read more